Tumor Burden and Clinical Benefit Assessment in Immunotherapy Clinical Trials

MessageThis Webinar is over
Date Sep 19, 2016
Time 10:30 AM EDT
Cost Free
This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy. Recommendations on when and how to apply each criterion will be reviewed as will case histories illustrating the clinical decision-making needed to determine if a patient should continue treatment.


Create your own event
Turn your passion into a business.
Join our mailing list